![baby](https://pharmaphorum.com/wp-content/uploads/2022/12/baby-g77188754f-840px.jpg)
FDA starts review of Sanofi, AZ antibody for RSV prevention
The clock has started ticking on the FDA's review of Sanofi and AstraZeneca's one-shot antibody to protect newborns and infants from respiratory syncytial virus (RSV), with a decision due i